Parallel Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.71M Buy
266,516
+22,286
+9% +$562K 0.1% 144
2026
Q1
$6.17M Buy
244,230
+2,429
+1% +$62K 0.11% 139
2025
Q4
$6.17M Buy
241,801
+14,326
+6% +$367K 0.11% 131
2025
Q3
$5.83M Buy
227,475
+9,299
+4% +$236K 0.11% 134
2025
Q2
$5.52M Buy
218,176
+17,384
+9% +$431K 0.11% 136
2025
Q1
$5.02M Sell
200,792
-6,273
-3% -$155K 0.11% 138
2024
Q4
$5.09M Buy
207,065
+34,713
+20% +$869K 0.11% 140
2024
Q3
$4.43M Buy
172,352
+67,360
+64% +$1.7M 0.1% 154
2024
Q2
$2.58M Buy
104,992
+7,972
+8% +$195K 0.07% 204
2024
Q1
$2.41M Buy
97,020
+44,143
+83% +$1.09M 0.07% 208
2023
Q4
$1.33M Buy
+52,877
New +$1.26M 0.04% 283

Other funds holding IBDX

Parallel Advisors's IBDX Position: Q2 2026 in Review

Parallel Advisors increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 9.1% in Q2 2026, buying an estimated $562K and bringing the position to 266,516 shares worth $6.71M. The position accounts for 0.1% of the portfolio, ranked #144.

Parallel Advisors first reported a position in IBDX in Q4 2023 and has held it in 11 quarters since. 150 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Parallel Advisors held 266,516 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $6.71M as of Q2 2026.
  • Parallel Advisors bought 22,286 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $562K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.1% of Parallel Advisors's portfolio in Q2 2026, its #144 holding.
  • Parallel Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 150 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.